Bruno V. Sinn

9.8k total citations · 3 hit papers
88 papers, 3.2k citations indexed

About

Bruno V. Sinn is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Bruno V. Sinn has authored 88 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 39 papers in Cancer Research and 29 papers in Molecular Biology. Recurrent topics in Bruno V. Sinn's work include Pancreatic and Hepatic Oncology Research (19 papers), Cancer Genomics and Diagnostics (17 papers) and Breast Cancer Treatment Studies (17 papers). Bruno V. Sinn is often cited by papers focused on Pancreatic and Hepatic Oncology Research (19 papers), Cancer Genomics and Diagnostics (17 papers) and Breast Cancer Treatment Studies (17 papers). Bruno V. Sinn collaborates with scholars based in Germany, United States and Switzerland. Bruno V. Sinn's co-authors include Carsten Denkert, Silvia Darb‐Esfahani, Jan Budczies, Frederick Klauschen, Wolfgang Schmitt, Balázs Győrffy, Manfred Dietel, Marcus Bahra, W. Fraser Symmans and Rebekah Gould and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Bruno V. Sinn

80 papers receiving 3.1k citations

Hit Papers

Cutoff Finder: A Comprehensive and Straightforward Web Ap... 2012 2026 2016 2021 2012 2017 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
    2012 954 citations Jan Budczies, Bruno V. Sinn et al. profile →
  2. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
    2017 417 citations W. Fraser Symmans, Rebekah Gould et al. Journal of Clinical Oncology profile →
  3. Causes of death and comorbidities in hospitalized patients with COVID-19
    2021 251 citations Jana Ihlow, Philip Bischoff et al. profile →

Peers

Bruno V. Sinn
Malin Sund Sweden
D. Vucicevic United States
Jin Gu China
Flora Zagouri Greece
Urban Emmenegger Canada
Ishmael Jaiyesimi United States
Benjamin Esterni France
Jun Gong United States
Masashi Ando Japan
Anna Spreafico Canada
Malin Sund Sweden
Bruno V. Sinn
Citations per year, relative to Bruno V. Sinn Bruno V. Sinn (= 1×) peers Malin Sund

Countries citing papers authored by Bruno V. Sinn

Since Specialization
Citations

This map shows the geographic impact of Bruno V. Sinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno V. Sinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno V. Sinn more than expected).

Fields of papers citing papers by Bruno V. Sinn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno V. Sinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno V. Sinn. The network helps show where Bruno V. Sinn may publish in the future.

Co-authorship network of co-authors of Bruno V. Sinn

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno V. Sinn. A scholar is included among the top collaborators of Bruno V. Sinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno V. Sinn. Bruno V. Sinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffmann, Inga, Jalid Sehouli, Gerald Niedobitek, et al.. (2025). Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer. Clinical Cancer Research. 31(18). 3956–3969.
2.
Habringer, Stefan, Jana Ihlow, Max Schmidt, et al.. (2024). A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric mass. The Oncologist. 29(10). 908–912.
3.
Sinn, Bruno V., M. Untch, Thomas Karn, et al.. (2024). On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer. Breast Cancer Research. 26(1). 138–138. 1 indexed citations
4.
Marczyk, Michał, Chunxiao Fu, Rosanna Lau, et al.. (2023). Assessment of stained direct cytology smears of breast cancer for whole transcriptome and targeted messenger RNA sequencing. Cancer Cytopathology. 131(5). 289–299. 4 indexed citations
5.
Roßner, Florian, Bruno V. Sinn, & David Horst. (2023). Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update. Cancers. 15(2). 494–494. 12 indexed citations
6.
Hoffmann, Inga, Mihnea P. Dragomir, Paul Jank, et al.. (2023). LRP1B—a prognostic marker in tubo-ovarian high-grade serous carcinoma. Human Pathology. 141. 158–168. 1 indexed citations
7.
Hoffmann, Inga, Mihnea P. Dragomir, Catarina Alisa Kunze, et al.. (2023). Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer. Neoplasia. 44. 100934–100934. 5 indexed citations
8.
9.
Wimberger, Pauline, Jens‐Uwe Blohmer, Petra Krabisch, et al.. (2023). The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy. Breast Cancer Research. 25(1). 32–32. 6 indexed citations
10.
Ihlow, Jana, Inga Hoffmann, Philip Bischoff, et al.. (2022). Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer. Cancers. 14(19). 4620–4620. 8 indexed citations
11.
Felsenstein, Matthäus, Mathilde Feist, Karl H. Hillebrandt, et al.. (2022). Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies?. Journal of Clinical Medicine. 11(9). 2367–2367. 21 indexed citations
12.
Leichsenring, Jonas, Christine Solbach, Thomas Karn, et al.. (2022). EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy. BMC Cancer. 22(1). 1040–1040.
13.
14.
Schneeweiß, Andreas, Sabine Seiler, Hans Tesch, et al.. (2020). Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto‐GBG 84 Trial. Journal of the American Heart Association. 9(23). e018143–e018143. 26 indexed citations
15.
Marczyk, Michał, Chunxiao Fu, Rosanna Lau, et al.. (2019). The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues. BMC Cancer. 19(1). 1189–1189. 41 indexed citations
16.
Sinn, Bruno V., Gϋnter von Minckwitz, Carsten Denkert, et al.. (2012). 8O_PR MUCIN-1 Protein and Mrna Expression in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Annals of Oncology. 23. ii17–ii17.
17.
Denkert, Carsten, Sibylle Loibl, Ralf Kronenwett, et al.. (2012). RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy. Annals of Oncology. 24(3). 632–639. 19 indexed citations
18.
19.
Faggad, Areeg, Silvia Darb‐Esfahani, Ralph M. Wirtz, et al.. (2009). Topoisomerase IIα mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis. Modern Pathology. 22(4). 579–588. 32 indexed citations
20.
Faggad, Areeg, Silvia Darb‐Esfahani, Ralph M. Wirtz, et al.. (2009). Expression of multidrug resistance‐associated protein 1 in invasive ovarian carcinoma: implication for prognosis. Histopathology. 54(6). 657–666. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malin Sund Breakdown of academic impact, for papers by D. Vucicevic Breakdown of academic impact, for papers by Jin Gu Breakdown of academic impact, for papers by Flora Zagouri Breakdown of academic impact, for papers by Urban Emmenegger Breakdown of academic impact, for papers by Ishmael Jaiyesimi Breakdown of academic impact, for papers by Benjamin Esterni Breakdown of academic impact, for papers by Jun Gong Breakdown of academic impact, for papers by Masashi Ando Breakdown of academic impact, for papers by Anna Spreafico
Rankless by CCL
2026